Straumann Holding AG (FRA:QS51) EBIT : €374 Mil (TTM As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Straumann Holding AG EBIT?

Straumann Holding AG's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was €34 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was €374 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Straumann Holding AG's annualized ROC % for the quarter that ended in Dec. 2023 was 4.50%. Straumann Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 7.58%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Straumann Holding AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 1.58%.

Straumann Holding AG EBIT Historical Data

The historical data trend for Straumann Holding AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Straumann Holding AG EBIT Chart

Straumann Holding AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

350.89

119.85

475.10

522.49

385.91

Straumann Holding AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial															156.16	373.80	134.03	340.69	33.50

Competitive Comparison of Straumann Holding AG's EBIT

For the Medical Instruments & Supplies subindustry, Straumann Holding AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Straumann Holding AG's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Straumann Holding AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Straumann Holding AG's EV-to-EBIT falls into.

Straumann Holding AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €374 Mil.

Straumann Holding AG (FRA:QS51) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Straumann Holding AG's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	242.582 * ( 1 - 54.74% )	/	( (2228.277	+	2655.293)	/ 2 )
=	109.7926132	/	2441.785
=	4.50 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3511.171	-	661.522	-	( 621.372	-	max(0, 980.04	-	1628.329	+	621.372	))
=	2228.277

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	3522.496	-	428.705	-	( 438.498	-	max(0, 757.285	-	1474.195	+	438.498	))
=	2655.293

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Straumann Holding AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	67.006	/	( ( (701.285 + max(26.917, 0))	+	(751.155 + max(288.37, 0)) )	/	2 )
=	67.006	/	( ( 728.202	+	1039.525 )	/	2 )
=	67.006	/	883.8635
=	7.58 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(608.92	+	368.85	+	29.187)	-	(661.522	+	0	+	318.518)
=	26.917

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(494.649	+	389.059	+	131.257)	-	(428.705	+	0	+	297.89)
=	288.37

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Straumann Holding AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	374.188	/	23725.965
	=	1.58 %

Straumann Holding AG EBIT Related Terms

Thank you for viewing the detailed overview of Straumann Holding AG's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Straumann Holding AG (FRA:QS51) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Straumann Holding AG (FRA:QS51) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

SAUHY:USA SAUHF:USA STMNz:UK 0QMV:UK STMN:Switzerland

Address

Peter Merian-Weg 12, Basel, CHE, 4002

Website

https://www.straumann-group.com

Straumann is a global leader in tooth replacement and orthodontics solutions. Its line of products includes dental implants, abutments, clear aligners, biomaterials, and computer-aided design/computer-aided manufacturing equipment. The company's core products are dental implants, and it holds roughly 30% of the global implant dentistry market, which is estimated to be worth roughly CHF 5.4 billion. Originally a pure premium implant player, Straumann entered the value market in 2012 with its acquisition of Neodent. Straumann now accounts for almost half of the global premium market and around 15% of the value market. While its premium product catalog is marketed under Straumann, its value brands include Neodent, Anthogyr, and Medentika as well as other local and regional brands.

Straumann Holding AG (FRA:QS51) Headlines

No Headlines